Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis.

Zhang, Ruimei; Xi, Xiangyu; Wang, Chunying; Pan, Yong; Ge, Changhua; Zhang, Liying; Zhang, Shuo; Liu, Huimei

Zhang, Ruimei; Xi, Xiangyu; Wang, Chunying; Pan, Yong; Ge, Changhua; Zhang, Liying; Zhang, Shuo; Liu, Huimei.

Affiliation

Zhang R; Department of Tuberculosis, Xuzhou Infectious Disease Hospital, Xuzhou, Jiangsu Province, PR China.
Xi X; Department of Tuberculosis, Xuzhou Infectious Disease Hospital, Xuzhou, Jiangsu Province, PR China.
Wang C; Department of Tuberculosis, Xuzhou Infectious Disease Hospital, Xuzhou, Jiangsu Province, PR China.
Pan Y; Department of Tuberculosis, Xuzhou Infectious Disease Hospital, Xuzhou, Jiangsu Province, PR China.
Ge C; Department of Tuberculosis, Xuzhou Infectious Disease Hospital, Xuzhou, Jiangsu Province, PR China.
Zhang L; Department of Tuberculosis, Xuzhou Infectious Disease Hospital, Xuzhou, Jiangsu Province, PR China.
Zhang S; Department of Tuberculosis, Xuzhou Infectious Disease Hospital, Xuzhou, Jiangsu Province, PR China.
Liu H; Department of Tuberculosis, Xuzhou Infectious Disease Hospital, Xuzhou, Jiangsu Province, PR China.

PLoS One ; 13(7): e0201025, 2018.

Article in En | MEDLINE | ID: mdl-30024982

Subject(s)

Antitubercular Agents/therapeutic use; Immunotherapy; Interleukin-2/therapeutic use; Mycobacterium tuberculosis/immunology; Tuberculosis/therapy; Drug Therapy, Combination; Humans; Prognosis; Tuberculosis/immunology; Tuberculosis/microbiology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Interleukin-2 / Immunotherapy / Mycobacterium tuberculosis / Antitubercular Agents Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2018 Type: Article

Fulltext

XML

PubMed Links

Search on Google